Proguanil
File:Proguanil Structural Formulae.png | |
File:Proguanil sf.png | |
Systematic (IUPAC) name | |
---|---|
1-(4-chlorophenyl)-2-(N'-propan-2-ylcarbamimidoyl) guanidine
|
|
Clinical data | |
Trade names | Paludrine |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
Routes of administration |
Oral |
Pharmacokinetic data | |
Metabolites | cycloguanine |
Biological half-life | ~20 h |
Identifiers | |
CAS Number | 500-92-5 |
ATC code | P01BB01 (WHO) |
PubChem | CID: 4923 |
DrugBank | DB01131 |
ChemSpider | 4754 |
UNII | S61K3P7B2V |
KEGG | D08428 |
ChEBI | CHEBI:8455 |
ChEMBL | CHEMBL1377 |
Chemical data | |
Formula | C11H16ClN5 |
Molecular mass | 253.731 g/mol |
|
|
|
|
(verify) |
Proguanil (chlorguanide, chloroguanide) is a prophylactic antimalarial drug.[1][2] When taken, it is converted to the active metabolite cycloguanil. Proguanil is effective against sporozoites. Proguanil hydrochloride is marketed as Paludrine by AstraZeneca.
It has been used for malarial prophylaxis in children with sickle cell disease living in malaria-endemic areas for many years.
It is on the World Health Organization's List of Essential Medicines, a list of the most important medication needed in a basic health system.[3]
Medical uses
Proguanil is usually taken in combination with another antimalarial drug, such as atovaquone[4] (e.g. in the combination Malarone) or chloroquine.[5]
Malarone has fewer side effects than mefloquine, but can be more expensive because it is taken daily.
Proguanil is taken with atovaquone for chloroquine-resistant and multidrug resistant strains of P. falciparum and P. vivax. Proguanil combined with atovaquone is sold under the tradename Malarone (GlaxoSmithKline).
Precautions
General precautions regarding proguanil involve watching out for feelings of sullenness and anxiety to a level outside the ordinary, when taking it over a period of several months.[citation needed] These may come on gradually and may not be immediately attributable to anything in particular.
Mechanism
One mode of action involves cyclization to form cycloguanil,[6] which binds to the DHFR enzyme of the parasite and inhibits the folic acid metabolism. However, proguanil itself may have an alternative mechanism of antimalarial action besides dihydrofolate reductase inhibition.[7]
See also
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references>
tag; parameter "group" is allowed only.
<references />
, or <references group="..." />
External links
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Importance of cytochromes in cyclization reactions: Quantum chemical study on a model reaction of proguanil to cycloguanil. Minhajul Arfeen, Dhilon S Patel, Sheenu Abbat, Nikhil Taxak, Prasad V Bharatam, Journal of Computational Chemistry, 2014, 35, 28, 2047-2055
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- Pages with reference errors
- Pages with broken file links
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Drugs with no legal status
- Articles with unsourced statements from February 2010
- Antimalarial agents
- Protozoal dihydrofolate reductase inhibitors
- Prodrugs
- Biguanides
- Chloroarenes
- World Health Organization essential medicines